GlassScriptPhysician profile
Alisha Wilke
NPI 1467906305
$2,977.98
in general payments reported to CMS, 2019-2025
24 companies · $800 in 2025
The $800 reported for 2025 was more than what 93% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $649 · 2023: $630 · 2024: $265 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.15 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.44 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $467.48 | 2021-2025 | |
| Astellas Pharma US INC | $337.87 | 2021-2025 | Veozah, Myrbetriq |
| Organon LLC | $317.48 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $147.08 | 2025 | Slynd, Twirla |
| Sage Therapeutics, LLC | $133.96 | 2021-2025 | Zurzuvae |
| Shield Therapeutics INC | $129.83 | 2025 | |
| Agile Therapeutics, INC. | $79.28 | 2021-2022 | |
| Hologic Sales and Service, LLC | $67.35 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Myriad Women'S Health, INC. | $64.13 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $60.47 | 2025 | Myfembree |
| Millicent US INC | $51.36 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Amgen INC. | $49.19 | 2021-2024 | Prolia, Evenity |
| Avion Pharmaceuticals | $46.38 | 2021 | |
| Evofem Biosciences, INC. | $42.81 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $41.56 | 2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $38.75 | 2021 | |
| Merck Sharp & Dohme LLC | $29.95 | 2021 | |
| Pfizer INC. | $27.88 | 2021-2022 | |
| Conmed Corporation | $27.08 | 2025 | Airseal |
| Dexcom, INC. | $23.72 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $23.14 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.15 | 2022 | |
| Mylan Pharmaceuticals INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Wilke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.